Ikarian Capital, LLC Precision Biosciences Inc Transaction History

Ikarian Capital, LLC

  • $573 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021
SELL
$5.98 - $12.47 $52,695 - $109,885
-8,812 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$4.66 - $8.7 $41,063 - $76,664
8,812 New
8,812 $73,000
Q1 2020

May 15, 2020
SELL
$5.05 - $15.01 $404,000 - $1.2 Million
-80,000 Closed
0 $0
Q4 2019

Jan 31, 2020
BUY
$6.32 - $19.66 $505,600 - $1.57 Million
80,000 New
80,000 $1.11 Million

Others Institutions Holding DTIL

# of Institutions
7
Shares Held
2.56M
Call Options Held
0
Put Options Held
0
View Full List

About PRECISION BIOSCIENCES INC

DTIL Quotes by TradingView
  • Ticker DTIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 110,818,000
  • Market Cap $842M
  • Description
  • Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...
More about DTIL
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email